コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 arotid artery stenting, 1105 who had carotid endarterectomy).
2 ma during the first 72 hours after pulmonary endarterectomy.
3 stenosis most likely to benefit from carotid endarterectomy.
4 sonance imaging, 46.9% (n=15) before carotid endarterectomy.
5 ues removed from patients undergoing carotid endarterectomy.
6 swelling in his left neck after left carotid endarterectomy.
7 r carotid artery stenting than after carotid endarterectomy.
8 with carotid artery stenting versus carotid endarterectomy.
9 o receive carotid artery stenting or carotid endarterectomy.
10 r measurements were obtained after pulmonary endarterectomy.
11 unger patients and in those not suitable for endarterectomy.
12 ients with carotid artery disease undergoing endarterectomy.
13 and absence of previous ipsilateral carotid endarterectomy.
14 r carotid artery stenting than after carotid endarterectomy.
15 iomarker+ only were more common with carotid endarterectomy.
16 owever, many cases can be cured by pulmonary endarterectomy.
17 stochemistry for patients undergoing carotid endarterectomy.
18 ssed over from ACP to DHCA to allow complete endarterectomy.
19 scular lung water variations after pulmonary endarterectomy.
20 coronary-artery bypass grafting and carotid endarterectomy.
21 of myocardial infarction (MI) after carotid endarterectomy.
22 o receive carotid artery stenting or carotid endarterectomy.
23 istics and outcome in men undergoing carotid endarterectomy.
24 carotid artery stenting with that of carotid endarterectomy.
25 d improve the risk-benefit ratio for carotid endarterectomy.
26 ry stenting and the group undergoing carotid endarterectomy.
27 o undergo carotid-artery stenting or carotid endarterectomy.
28 acy of carotid artery stenting compared with endarterectomy.
29 otid stenosis who are likely to benefit from endarterectomy.
30 a higher risk of myocardial infarction with endarterectomy.
31 obtained from patients who underwent carotid endarterectomy.
32 ary artery bypass graft surgery, and carotid endarterectomy.
33 ed 1 hour, 1 day, and 2 days after pulmonary endarterectomy.
34 li-protection device and those who underwent endarterectomy.
35 be similar to timing of stroke after carotid endarterectomy.
36 that outcomes may approach those of carotid endarterectomy.
37 receiving carotid stenting and 43 receiving endarterectomy.
38 thin the previous 5 days) undergoing carotid endarterectomy.
39 thy controls and patients undergoing carotid endarterectomy.
40 rs for 26 +/- 8 months before undergoing the endarterectomy.
41 d 30 nondiabetic patients undergoing carotid endarterectomy.
42 ng from a relative decline of 8% for carotid endarterectomy (1.3% mortality in 1999 and 1.2% in 2008)
43 decrease from 1999 to 2014 was observed for endarterectomy (1.4%; 95% CI, 1.2% to 1.5%) but not sten
44 ed with 16 (3.8%) of 417 assigned to carotid endarterectomy (1.84, 1.01-3.37; interaction p=0.064).
45 n increased rate of restenosis after carotid endarterectomy (2.26, 1.34-3.77) but not after carotid a
46 plan-Meier rate 6.0%) and 62 who had carotid endarterectomy (6.3%) had restenosis or occlusion (hazar
49 troke or death in patients receiving carotid endarterectomy, a harm of screening included the risk fo
51 s for 1-year ischemic stroke decreased after endarterectomy (absolute decrease, 3.5% [95% CI, 3.2% to
52 By comparing endovascular treatment with endarterectomy after the 30-day post-treatment period, t
54 h-grade stenosis derive benefit from carotid endarterectomy, although they have different risk profil
55 ith gene expression profiling of 121 carotid endarterectomies and an analysis of protein secretion by
56 2.63% to 3.18%) among patients who underwent endarterectomy and 1.13% (95% CI, 0.71% to 1.54%) among
57 th culprit carotid stenosis awaiting carotid endarterectomy and 8 controls without culprit carotid at
60 burden in women, review outcomes of carotid endarterectomy and carotid artery stenting in women, dis
64 eased between the first hour after pulmonary endarterectomy and day 2 (10.2 +/- 2.6 vs 11.4 +/- 3.6;
66 from 67% to 81% among patients who underwent endarterectomy and from 61% to 70% among patients who un
68 s well below the risk of carotid stenting or endarterectomy and has decreased markedly with more inte
69 mmon after endovascular treatment than after endarterectomy and is associated with recurrent ipsilate
71 rends in performance and outcomes of carotid endarterectomy and stenting among Medicare beneficiaries
72 ncluded immediate revascularization (carotid endarterectomy) and ongoing medical therapy (with antipl
73 en abdominal aortic aneurysm repair, carotid endarterectomies, and peripheral vascular operations com
77 thetic technique, and monitoring for carotid endarterectomy, and durability of stenting and angioplas
78 g, abdominal aortic aneurysm repair, carotid endarterectomy, aortic valve replacement, esophagectomy,
80 es such as iliac stenting and common femoral endarterectomy are commonly used to reduce operative ris
81 the endovascular arm than in patients in the endarterectomy arm (adjusted hazard ratio [HR] 3.17, 95%
86 id artery stenting (CAS) relative to carotid endarterectomy (CEA) among Medicare patients has not bee
87 he risk of stroke or death following carotid endarterectomy (CEA) and carotid artery stenting (CAS) o
88 dmission between patients undergoing carotid endarterectomy (CEA) and carotid artery stenting (CAS);
89 atients with carotid artery disease, carotid endarterectomy (CEA) and carotid stenting (CAS) are trea
90 al ischemic DWI lesions after CAS or carotid endarterectomy (CEA) are associated with an increased ri
91 s excluding dialysis patients showed carotid endarterectomy (CEA) decreased stroke risk compared with
93 roke is a persistent complication of carotid endarterectomy (CEA) for patients with symptomatic carot
94 tid artery stenting (CAS) and carotid artery endarterectomy (CEA) for the prevention of stroke due to
96 tomatic carotid artery stenosis with carotid endarterectomy (CEA) or carotid angioplasty and stenting
97 en the controversy regarding whether carotid endarterectomy (CEA) or carotid artery stenting (CAS) ma
98 sk of major adverse events following carotid endarterectomy (CEA) or carotid artery stenting (CAS), t
99 articles comparing early outcomes of carotid endarterectomy (CEA) or carotid stenting (CAS) in elderl
103 nal aortic aneurysm repair (OAR) and carotid endarterectomy (CEA) performed by very low-volume surgeo
104 ve studies of medical therapy alone, carotid endarterectomy (CEA) plus medical therapy, or carotid ar
105 r neurological symptoms), successful carotid endarterectomy (CEA) reduces stroke incidence for some y
107 be administered at the conclusion of carotid endarterectomy (CEA) to reverse the anticoagulant effect
108 strated that CAS was not inferior to carotid endarterectomy (CEA) when performed by physicians experi
109 has achieved clinical equipoise with carotid endarterectomy (CEA), as evidenced by 2 large U.S. rando
110 reatment than it was in patients assigned to endarterectomy (CEA), raising concerns about the long-te
111 ng carotid artery stenting (CAS) and carotid endarterectomy (CEA), with better CEA outcomes than CAS
112 CHS) is an important complication of carotid endarterectomy (CEA), yet prior research has been limite
116 sks of stroke and complications from carotid endarterectomy, costs, and quality of life values were e
117 re beneficiaries, the performance of carotid endarterectomy declined from 1999 to 2014, whereas the p
120 thout stenting) is an alternative to carotid endarterectomy for carotid artery stenosis but there are
122 dema is a specific complication of pulmonary endarterectomy for chronic thromboembolic pulmonary hype
123 the intervention in the 3 trials was carotid endarterectomy for patients with stenosis exceeding 50%
124 ents are an alternative treatment to carotid endarterectomy for symptomatic carotid stenosis, but pre
126 between carotid artery stenting and carotid endarterectomy for symptomatic or asymptomatic carotid s
127 nt data indicates a clear benefit of carotid endarterectomy for symptomatic patients with high-grade
128 Stenting is an endovascular alternative to endarterectomy for the management of carotid stenosis, b
129 tic carotid arteries were examined following endarterectomy for the presence of the Gram-positive bac
130 protection device is not inferior to carotid endarterectomy for the treatment of carotid artery disea
132 R) and OPN mRNA levels are higher in carotid endarterectomies from patients with symptoms (stroke, tr
133 e frequent in the stenting group than in the endarterectomy group (119 vs 72 events; ITT population,
135 end point between the stenting group and the endarterectomy group (7.2% and 6.8%, respectively; hazar
136 the stenting group compared with 5.2% in the endarterectomy group (72 vs 44 events; HR 1.69, 1.16-2.4
137 nfidence interval [CI], 9.1 to 14.8) and the endarterectomy group (9.9%; 95% CI, 7.9 to 12.2) over 10
138 eier estimate, 26.2%) and 45 patients in the endarterectomy group (cumulative incidence, 26.9%; Kapla
139 group compared with 27 (3.2%) events in the endarterectomy group (hazard ratio [HR] 1.28, 95% CI 0.7
142 97.8% in the stenting group and 97.3% in the endarterectomy group (P=0.51), and the overall survival
143 more cranial nerve palsies (22 vs 0) in the endarterectomy group than in the endovascular group.
145 ifference between the stenting group and the endarterectomy group with respect to the primary composi
146 atients in the stenting group and one in the endarterectomy group withdrew immediately after randomis
152 differed between the stenting group and the endarterectomy group: for death (0.7% vs. 0.3%, P=0.18),
153 in 5.6% (95% CI, 3.7 to 7.6) of those in the endarterectomy group; the rates did not differ significa
154 iffer significantly between the stenting and endarterectomy groups (6.4% vs 6.5%; hazard ratio [HR] 1
156 endovascular treatment and 213 patients had endarterectomy) had prospective clinical follow-up at a
157 arotid artery stenting and 28 MIs in carotid endarterectomy (hazard ratio, 0.50; 95% confidence inter
158 r death was 6.4% with stenting and 4.7% with endarterectomy (hazard ratio, 1.50; P=0.03); the rates a
159 ality were smoking history, previous carotid endarterectomy, hemoglobin level, and increasing age.
160 ed with 40 (4.9%) of 823 assigned to carotid endarterectomy (HR 0.90, 95% CI 0.57-1.41) and 31 (6.8%)
161 association in patients treated with carotid endarterectomy (HR for any stroke 1.18, 0.40-3.55; p=0.7
162 There were 81306 patients who underwent endarterectomy in 1999 and 36325 in 2014; national rates
163 an emboli-protection device as compared with endarterectomy in 334 patients at increased risk for com
164 on MR images would undergo immediate carotid endarterectomy in addition to ongoing intensive medical
165 ial (Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects Who Are at Stand
166 patients to compare CAS with EFD to carotid endarterectomy in different cohorts, such as patients at
168 ned to look back over the history of carotid endarterectomy in order to understand the evolution of c
169 stenting with embolic protection and carotid endarterectomy in patients 79 years of age or younger wh
170 ion") is an effective alternative to carotid endarterectomy in patients at average or high risk for s
171 higher risk of stroke compared with carotid endarterectomy in patients with an ARWMC score of 7 or m
173 ight be an acceptable alternative to carotid endarterectomy in patients with less extensive lesions.
174 between carotid artery stenting and carotid endarterectomy in patients with symptomatic and asymptom
175 lve the role of carotid stenting and carotid endarterectomy in primary and secondary stroke preventio
176 aques of patients undergoing primary carotid endarterectomy in the province of Utrecht from 2002 to 2
177 ven to be a potential alternative to carotid endarterectomy in the treatment of severe carotid diseas
180 W measured at the first hour after pulmonary endarterectomy is closely associated with reperfusion pu
183 the balance of risk and benefit for carotid endarterectomy is particularly narrow, and to explore an
186 ptomatic patients and treatment with carotid endarterectomy is unknown; the benefit is limited by a l
187 rotid artery stenting, compared with carotid endarterectomy, is emerging as an effective and less inv
188 with Protection in Patients at High Risk for Endarterectomy), looked at 1-year stroke, death, and MI
189 dy, 937111 unique patients underwent carotid endarterectomy (mean age, 75.8 years; 43% women) and 231
190 s in patients without symptoms after carotid endarterectomy, medical therapy of asymptomatic carotid
191 2 patients were randomly assigned to carotid endarterectomy (n=1240) or carotid artery stenting (n=12
192 atients were assigned to stenting (n=855) or endarterectomy (n=858) and followed up for a median of 4
193 egistry-Carotid Artery Revascularization and Endarterectomy (NCDR CARE) Registry, we compared patient
194 cal therapy-only group could undergo carotid endarterectomy only with substantial carotid artery sten
196 n, lower-extremity arterial disease, carotid endarterectomy or angioplasty, or abdominal aortic aneur
197 the odds of procedural intervention (carotid endarterectomy or carotid artery stenting) compared with
198 s deemed equally suitable for either carotid endarterectomy or endovascular treatment were randomly a
200 tice, decision making with regard to carotid endarterectomy or stenting is still primarily based on t
201 ials demonstrated the superiority of carotid endarterectomy over medical therapy in the prevention of
202 = 0.03); the effect was greatest in carotid endarterectomy patients (RB = 73.4% vs. no RB = 67.7%, P
204 nal 8 carotid artery stenting and 12 carotid endarterectomy patients had biomarker+ only (hazard rati
205 To evaluate surgical success after pulmonary endarterectomy (PEA) by means of cardiopulmonary magneti
207 rrent pulmonary hypertension after pulmonary endarterectomy (PEA) who were receiving the soluble guan
213 nd 4055 Carotid Artery Revascularization and Endarterectomy Registry (2824 CAS; 1231 CEA) Medicare pa
215 ) CARE (Carotid Artery Revascularization and Endarterectomy) Registry for carotid revascularization;
218 ughout follow-up with stenting suggests that endarterectomy remains the treatment of choice for carot
220 ing coronary artery bypass grafting, carotid endarterectomy, repair of nonruptured abdominal aortic a
221 atients with de novo atherosclerotic or post-endarterectomy restenotic lesions in native carotid arte
223 terion (OPC) of 12.6% for published surgical endarterectomy results in similar patients, plus a pre-s
224 comparing filter-protected CAS with carotid endarterectomy revealed a higher periprocedural stroke r
225 ssion in >70 samples obtained during carotid endarterectomy revealed that local miR-100 expression wa
228 With Protection in Patients at High Risk for Endarterectomy (SAPPHIRE) trial or Carotid Revasculariza
230 rosclerotic plaques harvested during carotid endarterectomy show a time-dependent change in plaque co
231 mong vascular patients scheduled for carotid endarterectomy significantly improved over the past deca
232 crophage content was assessed in all carotid endarterectomy specimens as a percentage of CD68(+)-stai
235 ix and associated molecules in human carotid endarterectomy specimens from 6 symptomatic versus 6 asy
236 ptake was compared with histology in carotid endarterectomy specimens from patients with symptomatic
243 tients aged 18-80 years undergoing pulmonary endarterectomy surgery in a UK centre (Papworth Hospital
245 In human plaques, collected during carotid endarterectomy surgery, we found that 14q32 microRNA (mi
247 event between 5 and 180 days of the carotid endarterectomy [symptomatic]) confirmed elevation of ser
248 restenosis after endovascular treatment and endarterectomy, the effect of the use of stents on reste
249 ired from on-going trials of stenting versus endarterectomy to ascertain whether long-term ultrasound
251 lesions in carotid arteries require surgical endarterectomy to reduce the risk of ischemic stroke.
253 th Protection of Patients with High Risk for Endarterectomy) trial demonstrated that CAS was not infe
256 Thirty-four patients undergoing carotid endarterectomy underwent screening of carotid atheroscle
257 irty-day stroke and death rates from carotid endarterectomy vary from 2.7% to 4.7% in RCTs; higher ra
260 (RCTs) of screening for CAS; RCTs of carotid endarterectomy versus medical treatment; systematic revi
262 vidence from randomized controlled trials of endarterectomy versus stenting shows a higher rate of st
266 In the randomised Carotid Revascularization Endarterectomy versus Stenting Trial (CREST), the primar
269 isk of CEA, CREST (Carotid Revascularization Endarterectomy Versus Stenting Trial) found no differenc
272 SAPPHIRE) trial or Carotid Revascularization Endarterectomy vs Stenting Trial (CREST) enrollment crit
274 aterial from the BiKE (Biobank of Karolinska Endarterectomies), we profiled miRNA expression in patie
275 aterial from the BiKE (Biobank of Karolinska Endarterectomies), we profiled miRNA expression in patie
276 ho had been randomly assigned to stenting or endarterectomy, we evaluated outcomes every 6 months for
278 aparoscopic cholecystectomies and 22 carotid endarterectomies were studied using direct observation m
279 arotid artery stenting compared with carotid endarterectomy were 6.2% versus 6.8% in men (hazard rati
280 were hemodynamically stable after pulmonary endarterectomy were divided into two groups based on whe
283 age +/- SD, 68.3 +/- 7.3) undergoing carotid endarterectomy were recruited for combined carotid (18)F
284 observational studies of harms from carotid endarterectomy were selected to answer the following que
285 of ipsilateral stroke with stenting and with endarterectomy were similarly low (2.0% and 2.4%, respec
286 Human atherosclerotic plaques obtained by endarterectomy were staged and analyzed for C5L2 and C5a
289 id artery stenting (CAS) relative to carotid endarterectomy when performed by physicians with demonst
290 artery stenting than those who have carotid endarterectomy whereas there is little difference in men
291 esent after surgery, most commonly following endarterectomy, which is a rare cause with an estimated
292 artery stenting (CAS) compared with carotid endarterectomy, which may differ in specific patient sub
293 nts at increased risk for complications from endarterectomy who had either a symptomatic carotid arte
294 the randomized trial data comparing carotid endarterectomy with carotid artery stenting and describe
296 l complications, stenting was noninferior to endarterectomy with regard to the rate of the primary co
297 o underwent stenting and those who underwent endarterectomy with respect to the risk of periprocedura
298 ubjects Who Are at Standard Risk for Carotid Endarterectomy With Significant Extracranial Carotid Ste
299 afety and efficacy of stenting with those of endarterectomy, with a particular focus on long-term out
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。